In AZD4573-sensitive breast cancer cells, the numbers of γ-H2AX foci in EdU-positive cells were increased by 3.5–4.8 fold within 3 h following AZD4573 treatment compared to controls (Fig. 2B). Here, H2AX is linked to breast cancer.